Details of the Drug
General Information of Drug (ID: DME4O5D)
| Drug Name |
LUF-5433
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
LUF-5433; CHEMBL60156; 15850-34-7; 4-methoxy-N-(4-phenyl-1,3-thiazol-2-yl)benzamide; (Z)-4-methoxy-N-(4-phenylthiazol-2(3H)-ylidene)benzamide; AC1LDKPI; N-(4-phenylthiazol-2-yl)-4-methoxybenzamide; Oprea1_747035; Oprea1_074264; Oprea1_345855; AC1Q49Y1; SCHEMBL2753298; MolPort-001-029-705; MolPort-003-712-982; ZINC1508173; STK401912; BDBM50097431; AKOS001303429; AKOS024573980; MCULE-3254711297; ST042073; 4-methoxy-N-(4-phenylthiazol-2-yl)benzamide; 4-Methoxy-N-(4-phenyl-thiazol-2-yl)-benzamide; SR-01000394983; SR-01000394983-1
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 310.4 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||||||||


